Effect of protective agents against cisplatin ototoxicity

American Journal of Otology

Volumn 21, Issue 4, 2000, Pages 513-520

  Rybak, Leonard P ^a   Husain, Kazim ^a   Morris, Craig ^a   Whitworth, Craig ^a   Somani, Satu ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

4 methylthiobenzoic acid; Cisplatin ototoxicity; Diethyldithiocarbamate; Ebselen

Indexed keywords

4 METHYLTHIOBENZOIC ACID; ANTIOXIDANT; BENZOIC ACID DERIVATIVE; CATALASE; CISPLATIN; DIETHYLDITHIOCARBAMIC ACID; EBSELEN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID; MALONALDEHYDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM RESPONSE; COCHLEA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; HEARING LOSS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; NEUROPROTECTION; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; AZOLES; BENZOIC ACIDS; CISPLATIN; COCHLEAR DISEASES; DISEASE MODELS, ANIMAL; DITIOCARB; DRUG EVALUATION, PRECLINICAL; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GLUTATHIONE; HEARING DISORDERS; LIPID PEROXIDATION; ORGANOSELENIUM COMPOUNDS; RATS; RATS, WISTAR;

EID: 0033916023     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Bodenner DL, Dcdon PC, Keng PC, et al. Selective protection against cisplatin-induced toxicity in kidney, gut and bone marrow by DDTC. Cancer Res 1986;46:2751-5.
2. Hamers FPT, Brakkee JH, Cavalletti E, et al. Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res 1993:53:544-9.
3. Rybak LP, Ravi R, Somani SM. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. FundAppl Toxicol 1995; 26:293-300.
4. Rybak LP. Cisplatinum associated hearing loss. J Laryngol Otol 1981;95:745-7.
5. Fausti S, James H, Schaffer H, et al. High frequency monitoring for early detection of cisplatin ototoxicity. Arch Ololaryngol Head NeckSurg 1993;! 19:661-5.
6. Ravi R, Somani SM, Rybak LP. Mechanism of cisplatin ototoxicity: antioxidant system. Phannacol Toxicol 1995:76:386-94.
7. Gandara DR, Wiebe VJ, Perez EA, et al. Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate. Crit Rev Oncol Hematol 1990;10:353-65.
8. Markman M, D'Acquito R, lannoti N, et al. Phase I trial at high dose intravenous cisplatin with simultaneous intravenous sodium thiosulphate. J Can Res Clin Oncol 1991;117:151-5.
9. Yuhas JM, Culo F. Selective inhibition of the nephrotoxicity of cisdichlorodiamminelatinum (II) by WR2721 without altering its antitumor properties. Cancer Treat Rep I980;64:57-64.
10. Somani SM, Ravi R, Rybak LP. Diethyldithiocarbamate protection against cisplatin nephrotoxicity: antioxidant system. Drug Chem Toxicol 1995:18:151-70.
11. Church MW, Kaltenbach JA, Blakely BW, et al. The comparative effects of sodium thiosulfate diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity. Hear Res 1995:86:195-203.
12. Zunino F, Pratesi G, Micheloni A, et al. Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug. Chem Biol Interact 1989;70:89-101.
13. Babu E, Gopal Krishnan VK, Sriganth IMP, et al. Cisplatininduced nephrotoxicity and the modulating effect of glutathione ester. Mol Cell Biochem 1995:144:7-11.
14. Campbell KCM, Rybak LP, Meech RP, et al. D-methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res 1996; 102:90-8.
15. Zhang JG, Zhong LF, Zhang M, et al. Protection effects of procaine on oxidative stress and toxicities of renal cortical slices from rats caused by cisplatin in vitro. Arch Toxicol 1992:66:354-8.
16. Esposito M, Viale M, Vamozzi OM, et al. Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cisdiamminedichloroplatinum (II). Toxicol AppI Phannacol 1996:140:370-7.
17. Basinger MA, Jones MM, Holscher MA. L-methionine antagonism of cis-platinum-induced nephrotoxicity. Toxicol Appl Phannacol 1990:103:1-15.
18. Boogaard PJ, Lempers EL, Mudler GJ, et al. 4-methylthiobenzoic acid reduces cisplatin nephrotoxicity in rats without compromising anti-tumor activity. Biochem Phannacol 1990;41:1997-2003.
19. Baldew GS, Van den Hamer CJA, Los G, et al. Selenium-induced protection against cis-diamminedichloroplatinum (II) nephrotoxicity in mice and rats. Cancer Res 1989:49:3020-3.
20. McGuiness JE, Proctor P, Demopoulos H. Amelioration of cisplatinum nephrotoxicity by orgotein (Superoxide dismutase). Pliysiol Client Phys 1978; 10:269-77.
21. Berry JM, Jacobs C, Sikic B, et al. Modification of cisplatin toxicity with diethyldithiocarbamate. J Clin Oitcol 1990;8:1585-90.
22. Gandara DR, Ferez EA, Weibe V, et al. Cisplatin chemoprotection and rescue: pharmacologie modulation of toxicity. Semin Oncol 199I;18:49-55.
23. Leemvenkamp OR, Van Der Vijgh WJ, Neijt JP, et ai. Reaction kinetics of cisplatin and its monaquated species with the (potential) renal protecting agents (di) mesna and thiosulfate. Estimation of the effect of protecting agents on the plasma and peritoneal AUCs of CDDP. Cancer Cliemother Pliarmacol 1990;27:lll-4.
24. Rybak LP, Husain K, Evenson L, et al. Protection by 4-methylthiobezoic acid against cisplatin ototoxicity: Antioxidant System. Pharmacol Toxicol 1997;81:173-9.
25. Maiorino M, Roveri A, Ursini F. Antioxidant effect of ebselen (PZ51): peroxidase mimetic activity on phospholipid and cholesterol hydroperoxides vs free radical scavenger activity. Arch Biochem Biophys 1992;295:404-9.
26. Muller A, Cadenas E, Graf P, et al. Glutathione peroxidase like activity in vitro and antioxidant capacity of PAS 1 (ebselen). Bioehern Pliarmacot 1984;33:3235-9.
27. Baldew GS, McVie JG, Vander Valk MA, et al. Selective reduction of cis-diamminedichloroplatinum (II) nephrotoxicity by ebselen. Cancer Res 1990;50:7031-6.
28. Leurs R, Timmerman H, Bast A. Inhibition of Superoxide anion radical production by ebselen (PZ51) and its sulfur analogue (PZ25) in guinea pig alveolar macrophages. Biocliem hit 1989;18: 295-9.
29. Fariss MW, Reed DJ. High performance liquid chromatography of thios and disulfides: dinitrophenol derivatives. Melh Enzymol 1987:143:101-9.
30. Misra HP, Fridovich I. The role of Superoxide anion in the autooxidation of the epinephrine and sample assay for Superoxide dismutase. J Bio! Chem 1972;247:3170-5.
31. Aebi N. Catalase in vitro. Melh Enzymol 1984;105:121-6.
32. Flohe L, Gunzler W. Assays of glutathione peroxidase. Meth Enzymol 1984;105:114-21.
33. Carlberg I, Mannervik B. Glutathione reductase. Meth Enzymol 1985;! 13:484-90.
34. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animals and tissue by thiobarbituric acid reaction. Anal Biochem 1979;95: 351-8.
35. Read SM, Northcole DH. Minimization of variation in the response to different protein of the coomassie blue G dye-binding assay for protein. Anal Biochem 1981:116:53-64.
36. Younes M, Siegers CP. Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in vivo. Chem Biol Interact 1981;34:257-66.
37. Otto NC, Brown RD, Gage-White L, et al. Effects of cisplatin and thiosulphate upon auditory brain stem responses of guinea pigs. Hear Res 1988;35:79-85.
38. Qazi R, Chang AY, Borch RF, et al. Phase I clinical and pharmacokinetic study of diethyldithiocarbamate as a chemoprotector from toxic effects of cisplatin. J Natl Cancer lust 1988;80:1486-8.
39. Huffman DW, Whitworth CA, Jones KL, et al. Potentiation of ototoxicity by glutathione depletion. Ann Owl Rhinol Laryngol 1988;97:36-41.
40. Clerici WJ, Hensley K, DiMartino DL, et al. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear expiants. Hear Res 1996;98:116-24.
41. Kopke RD, Garcia JP, Liu W, et al. The use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin induced damage of auditory hair cells. Am J Otol 1997; 18:559-71.
42. Ikeda K, Sunose H, Takasaka T. Effects of free radicals on the intracellular calcium concentration in the isolated outer hair cell of the guinea pig cochlea. Act Otolaryngol (Stockh) 1993:113:13741.
43. Clerici WJ, DiMartino DL, Prasad MR. Direct effects of reactive oxygen species on cochlear outer hair cell shape in vitro. Hear Res 1995:84:30-40.
44. DeWoskin RS, Riviere JE. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by a single dose of diethyldithiocarbamate but not mesna. Toxicol Appl Pharmacol 1992;112: 182-9.
45. Pigeolet E, Corbisier P, Houblon A, et al. Glutathione peroxidase, Superoxide dismutase and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ag Dev 1990;51:283-97.
46. Nogeuchi N, Yoshida Y, Kaneda H, et al. Action of ebselen against lipid peroxidation. Biochem Pharmacol 1992:44:39-44.
47. Ishikawa T. The ATP-dependant glutathione S-conjugate export pump. Trends Biochem Sei 1992;17:463-8.
48. Dawson DA, Masayaso M, Fraham DI, et al. The neuroprotective efficacy of ebselen (a glutathione peroxidase mimic) on brain damage induced by transient focal ischemia in the rat. Neurosci Lett 1995:185:65-9.